China Pharma Holdings (CPHI) Market Capitalization (2010 - 2026)

China Pharma Holdings (CPHI) has reported Market Capitalization for 17 consecutive years, with $26.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 358.03% year-over-year to $26.7 million; the trailing twelve-month figure through Jun 2026 stood at $26.7 million (up 358.03% YoY), and the FY2025 full-year result was $5.2 million, up 27.89% from the prior year.
• Market Capitalization climbed to $26.7 million in Q2 2026 per CPHI's latest filing, from $15.6 million in the prior quarter.
• Across five years, Market Capitalization topped out at $26.7 million in Q2 2026 and bottomed at $2.0 million in Q3 2023.
• Historically, Market Capitalization has averaged $7.7 million across 5 years, with a median of $5.3 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Market Capitalization plunged 82.51% in 2023, then surged 358.03% in 2026.
• Over 5 years, Market Capitalization stood at $5.0 million in 2022, then slumped by 59.39% to $2.0 million in 2023, then jumped by 98.35% to $4.1 million in 2024, then rose by 27.89% to $5.2 million in 2025, then surged by 415.05% to $26.7 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $26.7 million, $15.6 million, and $5.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.